In the Media
Are you looking for the latest media coverage of the BioMed X Institute, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!
Visit: The goal of our new XBridge program is to open a new door for researchers facing the sudden loss of support.
The goal of our new XBridge program is to open a new door for researchers facing the sudden loss of support.
Manager.bg
Visit: BioMed X has started a program to match researchers who have previously received funding from the U.S. National Institutes of Health (NIH) who have lost funding with supporters from the pharmaceutical industry.
BioMed X has started a program to match researchers who have previously received funding from the U.S. National Institutes of Health (NIH) who have lost funding with supporters from the pharmaceutical industry.
Thansettakij
Visit: BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
Sina Finance
Visit: BioMed X has launched a program to match U.S. National Institutes of Health fellows who have lost funding sponsors from the pharmaeceutical industry.
BioMed X has launched a program to match U.S. National Institutes of Health fellows who have lost funding sponsors from the pharmaeceutical industry.
Bloomberg Línea
Visit: BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
HKEJ
Visit: BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
CNYES
Visit: BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
Lianhe Zaobao